252 related articles for article (PubMed ID: 9306617)
1. Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck Plus in various clinical settings.
Ruzicka K; Kapiotis S; Quehenberger P; Handler S; Hornykewycz S; Michitsch A; Huber K; Clemens D; Susan M; Pabinger I; Eichinger S; Jilma B; Speiser W
Thromb Res; 1997 Sep; 87(5):431-40. PubMed ID: 9306617
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies.
Lawrie AS; Kitchen S; Purdy G; Mackie IJ; Preston FE; Machin SJ
Clin Lab Haematol; 1998 Jun; 20(3):179-86. PubMed ID: 9681235
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Q analyzer, a new cap-piercing fully automated coagulometer with clotting, chromogenic, and immunoturbidometric capability.
Kitchen S; Woolley A
Blood Coagul Fibrinolysis; 2013 Jan; 24(1):28-34. PubMed ID: 23249565
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Sysmex CS5100 coagulation analyzer and comparison to the Stago STA-R analyzer for routine coagulation parameters.
Geens T; Vertessen F; Malfait R; Deiteren K; Maes MB
Int J Lab Hematol; 2015 Jun; 37(3):372-81. PubMed ID: 25233923
[TBL] [Abstract][Full Text] [Related]
5. Point of care measurement of lepirudin and heparin anticoagulation during systemic inflammation.
Homoncik M; Pernerstorfer T; Reiter R; Knechtelsdorfer M; Quehenberger P; Jilma B
Thromb Res; 2002 Oct; 108(1):91-5. PubMed ID: 12586138
[TBL] [Abstract][Full Text] [Related]
6. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery.
Despotis GJ; Santoro SA; Spitznagel E; Kater KM; Barnes P; Cox JL; Lappas DG
Anesthesiology; 1994 Feb; 80(2):338-51. PubMed ID: 8311316
[TBL] [Abstract][Full Text] [Related]
7. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors.
Favaloro EJ; Kershaw G; Mohammed S; Lippi G
Semin Thromb Hemost; 2019 Feb; 45(1):22-35. PubMed ID: 30630206
[TBL] [Abstract][Full Text] [Related]
8. [Difference in examination of coagulation function in heparin anticoagulant therapy between point of care tests and automatic coagulation analyzer].
Li J; Cong YL; Tu GH; Yang L; Zhu BB; Jin L
Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1269-71. PubMed ID: 17686264
[TBL] [Abstract][Full Text] [Related]
9. Mixing Studies in Patients With Prolonged Activated Partial Thromboplastin Time or Prothrombin Time.
Benzon HT; Park M; McCarthy RJ; Kendall MC; Lindholm PF
Anesth Analg; 2019 Jun; 128(6):1089-1096. PubMed ID: 31094773
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a new thromboplastin reagent STA-NeoPTimal on a STA R Max analyzer for the measurement of prothrombin time, international normalized ratio and extrinsic factor levels.
Mullier F; Paridaens MS; Evrard J; Baudar J; Guldenpfennig M; Devroye C; Miller L; Chatelain B; Lessire S; Jacqmin H
Int J Lab Hematol; 2020 Oct; 42(5):650-660. PubMed ID: 32426926
[TBL] [Abstract][Full Text] [Related]
11. Use of a centrifugal analyzer for a chromogenic prothrombin time, a chromogenic activated partial thromboplastin time and a kinetic fibrinogen assay in a routine hospital laboratory.
de Metz M; van Wersch JW
Haemostasis; 1987; 17(5):254-9. PubMed ID: 3666583
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and performance characteristics of the Q Hemostasis Analyzer, an automated coagulation analyzer.
Toulon P; Fischer F; Appert-Flory A; Jambou D
Thromb Res; 2014 May; 133(5):927-35. PubMed ID: 24650798
[TBL] [Abstract][Full Text] [Related]
13. Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time.
Burns ER; Goldberg SN; Wenz B
Am J Clin Pathol; 1993 Aug; 100(2):94-8. PubMed ID: 8356955
[TBL] [Abstract][Full Text] [Related]
14. Standardization of coagulation tests.
Opartkiattikul N
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a point-of-care coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and activated clotting time in dogs.
Tseng LW; Hughes D; Giger U
Am J Vet Res; 2001 Sep; 62(9):1455-60. PubMed ID: 11560277
[TBL] [Abstract][Full Text] [Related]
16. Point-of-care coagulation testing for assessment of the pharmacodynamic anticoagulant effect of direct oral anticoagulant.
Mani H; Herth N; Kasper A; Wendt T; Schuettfort G; Weil Y; Pfeilschifter W; Linnemann B; Herrmann E; Lindhoff-Last E
Ther Drug Monit; 2014 Oct; 36(5):624-31. PubMed ID: 24577124
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a bench-top coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and fibrinogen concentrations in healthy dogs.
Mineo HK; Garabed RB
Am J Vet Res; 2007 Dec; 68(12):1342-7. PubMed ID: 18052739
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of Routine Coagulation Tests in Healthy Children Undergoing Elective Minor Surgery: a 12-Year Retrospective Study.
Song J; Jung HW; Lee EH; Chang HK; Yoon HS
Clin Lab; 2021 Dec; 67(12):. PubMed ID: 34910442
[TBL] [Abstract][Full Text] [Related]
19. Assessment of a new instrument (Coag-A-Mate X2) for performing global clotting tests and specific factor assays.
Cugno MM; Chantarangkul V; Tripodi A; Mannucci PM
Clin Lab Haematol; 1985; 7(1):75-81. PubMed ID: 4006406
[TBL] [Abstract][Full Text] [Related]
20. Use of the activated partial thromboplastin time for the diagnosis of congenital coagulation disorders: problems and possible solutions.
Barna L; Triplett DA
Ric Clin Lab; 1989; 19(4):345-54. PubMed ID: 2517350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
